Japanese Packaging Stock News

TSE:4503
TSE:4503Pharmaceuticals

How Positive PADCEV Keytruda Phase 3 Perioperative Data At Astellas Pharma (TSE:4503) Has Changed Its Investment Story

Pfizer and Astellas Pharma recently reported positive Phase 3 EV-304 results showing PADCEV plus Keytruda cut the risk of tumor recurrence, progression or death in cisplatin-eligible muscle-invasive bladder cancer patients versus standard gemcitabine and cisplatin. The combination also achieved higher event-free survival, overall survival and pathological complete response rates with a consistent safety profile, potentially reinforcing PADCEV’s role in earlier-stage bladder cancer...
TSE:8424
TSE:8424Diversified Financial

Assessing Fuyo General Lease’s Valuation As 2026 Restructuring Plans Refocus The Business

Organizational overhaul puts Fuyo General Lease (TSE:8424) in focus Fuyo General Lease (TSE:8424) is drawing investor attention after announcing an organizational overhaul planned for April 2026 that will add new energy and risk units and reshape its real estate and regional divisions. The company is also promoting and appointing executives across corporate, financial, real estate, ICT, and compliance functions, aiming to align management responsibilities more closely with its core leasing,...
TSE:4502
TSE:4502Pharmaceuticals

What Takeda Pharmaceutical (TSE:4502)'s Pediatric ENTYVIO Phase 3 Success Means For Shareholders

In February 2026, Takeda announced positive Phase 3 KEPLER trial results showing ENTYVIO (vedolizumab) induced clinical remission in children aged 2–17 with moderately to severely active ulcerative colitis, and said it plans regulatory submissions in the US, EU and other markets. The data highlight ENTYVIO’s potential to extend a key gastroenterology therapy into a pediatric population where treatment options are limited, reinforcing Takeda’s focus on high-need specialty indications. We’ll...
TSE:7380
TSE:7380Banks

A Look At Juroku Financial Group (TSE:7380) Valuation After Planned IBIDEN Share Sale To Improve Capital Efficiency

Juroku Financial GroupInc (TSE:7380) is back in focus after its main bank unit moved to sell 1,740,000 IBIDEN shares, aiming to cut cross shareholdings and record a gain this fiscal year. See our latest analysis for Juroku Financial GroupInc. At a share price of ¥9,950, Juroku Financial GroupInc has seen a 21.34% 1 month share price return and a 57.44% 3 month share price return. Its 1 year total shareholder return of 128.35% and very large 5 year total shareholder return suggest momentum has...
TSE:4613
TSE:4613Chemicals

A Look At Kansai Paint (TSE:4613) Valuation After Its Board And Executive Realignment

Kansai Paint (TSE:4613) has approved a realignment of directors and executive officers, promoting regional leaders and appointing new Audit & Supervisory Board members to better match its increasingly international footprint. See our latest analysis for Kansai Paint. These leadership changes come as Kansai Paint’s 1 month share price return of 10.14% and 3 month share price return of 14.64% feed into a 1 year total shareholder return of 33.48%, suggesting momentum has been building over a...
TSE:6723
TSE:6723Semiconductor

How Toyota RAV4 ADAS Win and New 3nm SoCs Could Impact Renesas Electronics (TSE:6723) Investors

Renesas Electronics recently announced that its R-Car V4H ADAS system-on-chip was chosen for the TSS(LSS) control unit in Toyota’s RAV4 launched in December 2025, supplied by Denso, while also unveiling new 3nm TCAM and multi-domain automotive SoC technologies aimed at higher performance, safety and power efficiency. These wins and innovations highlight Renesas’ role at the core of next-generation automotive electronics, from sensor-fusion and driver monitoring in mass-market vehicles to...
TSE:9508
TSE:9508Electric Utilities

Kyushu Electric Power Company (TSE:9508) Valuation After New TeraWatt Energy Storage Alliance

Alliance with TeraWatt puts energy storage in focus Kyushu Electric Power Company (TSE:9508) has entered a capital and business alliance with U.S. based TeraWatt Technology, bringing battery storage into focus and highlighting how this could shape the utility's renewable energy ambitions for shareholders. See our latest analysis for Kyushu Electric Power Company. At a share price of ¥1,940.0, Kyushu Electric Power has seen a 12.63% 1 month share price return and 16.17% 3 month share price...
TSE:1801
TSE:1801Construction

Is Taisei (TSE:1801) Quietly Rebalancing From Construction Earnings To Real-Asset Ownership?

On February 26, 2026, Taisei Corporation held a board meeting to consider an equity investment in Tenjin 1-Chome Kaihatsu Project Tokutei Mokuteki Kaisha and to review appointments of representative directors and other executives. This combination of a potential real estate-focused equity commitment and possible leadership changes highlights how Taisei may be refining its capital allocation and governance priorities. Next, we will examine how the potential Tenjin 1-Chome Kaihatsu equity...
TSE:6503
TSE:6503Electrical

Mitsubishi Electric (TSE:6503) Valuation After Leadership Reshuffle And Smart Elevator Growth Focus

Mitsubishi Electric (TSE:6503) has moved to reorganize its leadership and internal structure following a February 19 board meeting, while also being cited among major players in the growing smart elevator market. See our latest analysis for Mitsubishi Electric. These leadership and organizational changes come after a period of strong market interest, with a 30 day share price return of 23.77% and a one year total shareholder return of 158.76%. This suggests momentum has been building rather...
TSE:8053
TSE:8053Trade Distributors

Assessing Sumitomo’s (TSE:8053) Valuation After Completing Its ¥80b Share Buyback Program

Buyback completion and what it means for Sumitomo shareholders Sumitomo (TSE:8053) has wrapped up its share repurchase program, buying back 17,714,775 shares for about ¥80b, after acquiring 4,262,700 shares between January 1 and February 19, 2026. See our latest analysis for Sumitomo. That buyback completion comes alongside strong share price momentum, with the stock up 3.5% over the last day and posting a 37.2% 90 day share price return. The 1 year total shareholder return of about 106%...
TSE:4568
TSE:4568Pharmaceuticals

Did EMA’s ENHERTU Validation and Leadership Changes Just Reframe Daiichi Sankyo’s (TSE:4568) Investment Narrative?

In February 2026, Daiichi Sankyo received European Medicines Agency validation to expand the indication of ENHERTU for HER2 positive early breast cancer, while also announcing leadership transitions including a new Global Head of R&D and upcoming changes to its board and audit members. These developments, alongside a new AI-driven collaboration with BostonGene and ongoing litigation linked to past disputes, highlight how Daiichi Sankyo is reshaping its oncology innovation engine and...
TSE:6752
TSE:6752Consumer Durables

Panasonic LUMIX Mic Launch Adds Interest To Valuation And Momentum Story

Panasonic Holdings launched the DMW-DMS1 Digital Shotgun Microphone for its LUMIX camera lineup. The new accessory introduces six selectable directional modes, 32-bit float recording and wind-noise suppression. The microphone connects without cables to compatible LUMIX cameras, aiming to offer more flexible and reliable audio capture for creators. For investors watching Panasonic Holdings (TSE:6752), this launch adds a fresh piece to the company’s imaging ecosystem at a time when demand for...
TSE:8035
TSE:8035Semiconductor

Assessing Tokyo Electron’s Valuation After Powerful 1 Year Momentum And Rising P/E Premium

What Tokyo Electron’s recent performance tells you right now Without a single headline event driving Tokyo Electron (TSE:8035) today, the stock’s recent moves still give you some useful context. The shares are around ¥44,010, with a month return of about 6.5% and a past 3 months return near 39%. See our latest analysis for Tokyo Electron. That recent 6.5% 1 month share price return and strong 39.1% 3 month share price return sit alongside a 1 year total shareholder return of 103.9%, so...
TSE:6301
TSE:6301Machinery

Komatsu Leadership Shift Puts Focus On Valuation And Momentum

Komatsu (TSE:6301) has appointed Taisuke Kusaba as Representative Director and Senior Executive Officer. Former senior executive Takeshi Horikoshi will step back from frontline management and move into an advisory role. The leadership changes mark a shift in board level responsibilities and executive oversight at the company. For investors watching Komatsu at ¥7,533.0, these leadership moves come after a strong share price run, with the stock up 27.1% over the past month, 48.7% year to...
TSE:6701
TSE:6701IT

Is It Time To Reassess NEC (TSE:6701) After Its Recent Share Price Pullback

If you are wondering whether NEC's share price still offers value after a strong run, this article will walk through what the current market is really implying about the stock. NEC recently closed at ¥4,334, with returns of 10.7% over 7 days, a 21.7% decline over 30 days, a 20.2% decline year to date, and gains of 51.0% over 1 year, 366.3% over 3 years and 266.2% over 5 years. These mixed short term moves alongside strong multi year returns have put the question of valuation firmly in focus...
TSE:7912
TSE:7912Commercial Services

A Look At Dai Nippon Printing (TSE:7912) Valuation After New 2nm Semiconductor Investment Move

Rapidus funding move puts DNP’s semiconductor ambitions in focus Dai Nippon Printing (TSE:7912) has joined Rapidus Corporation’s latest funding round, backing plans to establish mass production of 2nm logic semiconductors by 2027 and committing support through EUV lithography photomask development. See our latest analysis for Dai Nippon Printing. The Rapidus investment headlines come as Dai Nippon Printing’s share price has gained momentum, with a 30 day share price return of 17.92% and a...
TSE:9434
TSE:9434Wireless Telecom

SoftBank (TSE:9434) Valuation Check After AgentRAN AI Network Showcase At MWC Barcelona 2026

SoftBank (TSE:9434) is in focus after joining Northeastern University, Keysight Technologies, and zTouch Networks at MWC Barcelona 2026 to showcase AgentRAN, an autonomous AI-driven system for configuring 5G and 6G networks in real time. See our latest analysis for SoftBank. Against this backdrop, SoftBank’s recent product showcase comes as the share price sits at ¥213.8, with a 30 day share price return of 2.79% and a 90 day share price return that reflects a 4.21% decline. The 1 year, 3...
TSE:6963
TSE:6963Semiconductor

Assessing ROHM (TSE:6963) Valuation After New GaN Licensing Deal With TSMC

ROHM (TSE:6963) has put its GaN power business in focus after deciding to license TSMC’s GaN process technology and integrate it into its own development and manufacturing flow within the ROHM Group. See our latest analysis for ROHM. Investors appear to be reacting positively to ROHM’s GaN push, with the latest share price at ¥2,876 and a 90 day share price return of 37.28% feeding into a 1 year total shareholder return of 98.55%, which points to strong recent momentum. If this GaN licensing...
TSE:8630
TSE:8630Insurance

Is It Too Late To Consider Sompo Holdings (TSE:8630) After A 46% One Year Rally?

If you are wondering whether Sompo Holdings is still good value after its recent run, this article will walk through what the current share price might be saying about the company. The stock last closed at ¥6,245, with returns of 5.8% over 7 days, 18.5% over 30 days, 15.0% year to date and 45.7% over 1 year, while the 3 year return is described as very large and the 5 year return is approaching 5x. Recent news around Sompo Holdings has focused on the business and its sector, giving investors...
TSE:9684
TSE:9684Entertainment

How Investors May Respond To Square Enix (TSE:9684) Shifting Final Fantasy Toward Recurring Multi‑Platform Revenues

Square Enix has recently launched a new console cycle for its flagship Final Fantasy franchise while pushing to reduce its reliance on hit-driven, console-only releases by expanding across mobile, PC, and transmedia platforms. This pivot toward steadier, higher-margin and more diversified revenue streams comes as Japanese companies face rising pressure to improve corporate governance and shareholder returns, potentially reshaping how investors view Square Enix’s earnings profile. We will now...
TSE:9501
TSE:9501Electric Utilities

What Tokyo Electric Power Company Holdings (TSE:9501)'s New Fukushima Grant Means For Shareholders

Tokyo Electric Power Company Holdings recently received an additional ¥8.6 billion grant from the Nuclear Damage Compensation and Decommissioning Facilitation Corporation, lifting total Fukushima-related assistance to more than ¥11.47 billion as it prepares for further compensation payouts by March 2026. This latest tranche of government support highlights the enduring financial weight of Fukushima liabilities on TEPCO’s balance sheet and its ongoing commitment to compensating affected...
TSE:6588
TSE:6588Tech

A Look At Toshiba Tec (TSE:6588) Valuation As Leadership And Governance Are Refreshed

Toshiba Tec (TSE:6588) has announced a broad refresh of its leadership, including promoting long time insider Yasuki Ohnishi to President and COO, and reshaping its board and audit oversight roles. See our latest analysis for Toshiba Tec. The refreshed leadership story is arriving alongside strong recent momentum, with a 1 month share price return of 29.01% and a year to date share price return of 20.48%. However, the 3 year total shareholder return of a 13.28% decline and 5 year total...
TSE:8604
TSE:8604Capital Markets

Will Nomura’s New Lending Head Sharpen Its Regional Strategy or Highlight Structural Limits? (TSE:8604)

Nomura Holdings has appointed Etienne Broussaud, previously a managing director at UBS and formerly with Societe Generale, as head of lending and credit solutions for Southeast Asia, the Middle East, and Africa, based in Singapore and reporting to COO Sudhir Nemali. This hire brings deep experience in structured lending, risk solutions, and equity-related financing into Nomura’s wealth and investment businesses across several growth-focused regions. Next, we’ll examine how bringing in...
TSE:4516
TSE:4516Pharmaceuticals

Should NS-863’s Dual Phase 2 Cardiopulmonary Push Require Action From Nippon Shinyaku (TSE:4516) Investors?

Nippon Shinyaku recently reported progress on two Phase 2 trials of its oral candidate NS-863, targeting pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease, both serious cardiopulmonary conditions with high unmet need. By advancing NS-863 across two related indications, the company is signaling a deeper push into rare cardiopulmonary therapeutics, potentially broadening its specialty portfolio. We’ll now examine how this dual Phase 2 progress...